Jefferies Group's BBNX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 90,015 shares of Beta Bionics, Inc. (BBNX) worth $1.71 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in BBNX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 90,015 shares. Largest reduction occurred in Q1 2026, reducing 51,400 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +90,015 | New Buy | 90,015 | $18.98 |
| Q1 2026 | -51,400 | Sold Out | 0 | $0.00 |
| Q4 2025 | +51,400 | New Buy | 51,400 | $30.47 |
Jefferies Group's Beta Bionics Investment FAQs
Jefferies Group first purchased Beta Bionics, Inc. (BBNX) in Q4 2025, acquiring 51,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Beta Bionics, Inc. (BBNX) for 3 quarters since Q4 2025.
Jefferies Group's largest addition to Beta Bionics, Inc. (BBNX) was in Q3 2026, adding 90,015 shares worth $1.71 M.
According to the latest 13F filing for Q3 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 90,015 shares of Beta Bionics, Inc. (BBNX), valued at approximately $1.71 M.
As of the Q3 2026 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Beta Bionics, Inc. (BBNX) was 90,015 shares, as reported at the end of Q3 2026.